Alopecia (hair loss) is a progressive, multifactorial condition that has different forms and causes, determined by a combination of both genetic and extrinsic factors. The combination of both factors should be addressed as a whole during alopecia treatment. Approximately 80 million men and women in the United States alone suffer from hair loss and hair thinning. The most common hair loss type, known as androgenetic alopecia, is hereditary. If left untreated, hair loss usually progresses over time. TrichoTest delivers invaluable information to support practitioners in developing the optimal treatment plan for each patient.

TrichoTest is an innovative genetic test that supports practitioners, prescribers, and other licensed healthcare professionals to personalize alopecia (hair loss) treatments for their patients. 3 polymorphisms within 16 SNPs, resulting in 48 (3x16) genetic variations related to alopecia, are analyzed using state-of-the-art DNA OpenArray technology that is 99.9% reproducible. The resulting TrichoTest report is comprehensive and easy to understand. Further, the report provides information from the Medical Director at GX Sciences to assist the practitioner in creating a treatment plan for the patient.